Analysis of CD4 + CD8 + double‐positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions
Author(s) -
Waschbisch A.,
Sammet L.,
Schröder S.,
Lee D.H.,
BarrantesFreer A.,
Stadelmann C.,
Linker R. A.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12345
Subject(s) - natalizumab , multiple sclerosis , cerebrospinal fluid , immunology , cytotoxic t cell , flow cytometry , cd8 , immune system , medicine , biology , pathology , in vitro , biochemistry
Summary T cells with a CD4 + CD8 + double‐positive ( DP ) phenotype are present in small numbers in the peripheral blood of healthy humans and may have anti‐viral capacities. Here we investigate numbers and function of DP T cells in patients with relapsing–remitting multiple sclerosis ( MS ), either treatment‐naive or under therapy with natalizumab. Flow cytometry analysis revealed that frequencies of circulating DP T cells in treatment‐naive and natalizumab‐treated MS patients are comparable to healthy controls. These cells have a memory phenotype with cytotoxic potential, express high levels of CD49d and are similarly functional in treatment‐naive as well as natalizumab‐treated MS patients. DP T cells were enriched in the cerebrospinal fluid, but do not invade acutely inflamed MS lesions. In conclusion, DP T cells are functional in MS and may play a role in the immune surveillance of the central nervous system, but do not display functional impairment under natalizumab therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom